Published in JAMA on January 05, 2005
Effect of Ginseng in Type 2 Diabetes | NCT02923453
Prader-Willi Syndrome Macronutrient Study | NCT02011360
Cardiovascular Outcomes Of Diet Counseling | NCT00324545
A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss (RENEWAL) | NCT03515889
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med (2009) 12.38
The metabolic syndrome. Endocr Rev (2008) 5.33
Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann Intern Med (2014) 5.31
Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA (2012) 4.33
Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med (2015) 3.79
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med (2010) 3.73
Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery. Surg Obes Relat Dis (2007) 3.67
Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms. Am J Clin Nutr (2008) 3.02
Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation (2012) 2.82
Effect of Allowing Choice of Diet on Weight Loss: A Randomized Trial. Ann Intern Med (2015) 2.70
How to prevent obesity in developed countries--part 2. MedGenMed (2005) 2.65
Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun (2013) 2.29
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med (2010) 2.21
Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol (2015) 2.11
Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring) (2011) 2.08
Low carbohydrate versus isoenergetic balanced diets for reducing weight and cardiovascular risk: a systematic review and meta-analysis. PLoS One (2014) 2.03
"They all work...when you stick to them": a qualitative investigation of dieting, weight loss, and physical exercise, in obese individuals. Nutr J (2008) 1.99
Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr (2012) 1.96
A Simple Model Predicting Individual Weight Change in Humans. J Biol Dyn (2011) 1.84
Physician communication techniques and weight loss in adults: Project CHAT. Am J Prev Med (2010) 1.70
Adherence to a behavioral weight loss treatment program enhances weight loss and improvements in biomarkers. Patient Prefer Adherence (2009) 1.67
Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study. Int J Obes (Lond) (2008) 1.63
The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost. Trials (2009) 1.62
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61
The case for low carbohydrate diets in diabetes management. Nutr Metab (Lond) (2005) 1.61
Changes in self-efficacy and dietary adherence: the impact on weight loss in the PREFER study. J Behav Med (2007) 1.59
Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) (2005) 1.59
Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis. Am J Clin Nutr (2011) 1.55
A community programme to reduce salt intake and blood pressure in Ghana [ISRCTN88789643]. BMC Public Health (2006) 1.55
Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol (2011) 1.53
Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate (2008) 1.50
Combining behavioral weight loss treatment and a commercial program: a randomized clinical trial. Obesity (Silver Spring) (2013) 1.50
The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies. Nutr Metab Cardiovasc Dis (2014) 1.48
The development and description of the comparison group in the Look AHEAD trial. Clin Trials (2011) 1.46
The effect of a low-carbohydrate diet on bone turnover. Osteoporos Int (2006) 1.46
Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care (2009) 1.45
Participant recruitment and retention in a pilot program to prevent weight gain in low-income overweight and obese mothers. BMC Public Health (2009) 1.44
Retracted The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI J (2016) 1.44
Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial. Am J Clin Nutr (2015) 1.42
Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol (2012) 1.40
Self-regulatory processes and exercise adherence in older adults: executive function and self-efficacy effects. Am J Prev Med (2011) 1.37
Understanding nutritional epidemiology and its role in policy. Adv Nutr (2015) 1.37
Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation (2011) 1.37
Meat consumption is associated with obesity and central obesity among US adults. Int J Obes (Lond) (2009) 1.37
Anti-obesity drugs: past, present and future. Dis Model Mech (2012) 1.36
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol (2009) 1.34
Successful weight loss among obese U.S. adults. Am J Prev Med (2012) 1.31
Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J Clin Endocrinol Metab (2008) 1.30
Place of birth, duration of residence, neighborhood immigrant composition and body mass index in New York City. Int J Behav Nutr Phys Act (2008) 1.24
Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations. Am J Clin Nutr (2008) 1.23
Effect of dietary adherence with or without exercise on weight loss: a mechanistic approach to a global problem. J Clin Endocrinol Metab (2009) 1.21
Behavioral and pharmacologic therapies for obesity. Nat Rev Endocrinol (2010) 1.20
Evaluation of the effectiveness of making Weight Watchers available to Tennessee Medicaid (TennCare) recipients. J Gen Intern Med (2012) 1.19
Retracted Nuts as a replacement for carbohydrates in the diabetic diet. Diabetes Care (2011) 1.17
A dietary quality comparison of popular weight-loss plans. J Am Diet Assoc (2007) 1.15
Dietary practices, dining out behavior, and physical activity correlates of weight loss maintenance. Prev Chronic Dis (2007) 1.15
The association between weight loss and engagement with a web-based food and exercise diary in a commercial weight loss programme: a retrospective analysis. Int J Behav Nutr Phys Act (2011) 1.14
Imaging of brain dopamine pathways: implications for understanding obesity. J Addict Med (2009) 1.14
Interventions to enhance adherence to dietary advice for preventing and managing chronic diseases in adults. Cochrane Database Syst Rev (2013) 1.14
Intakes of fruits, vegetables and carbohydrate and the risk of CVD. Public Health Nutr (2008) 1.13
Dietary protein and risk of ischemic heart disease in middle-aged men. Am J Clin Nutr (2010) 1.13
Predictors of long-term weight loss in adults with modest initial weight loss, by sex and race. Obesity (Silver Spring) (2011) 1.12
Motivational interviewing as an intervention to increase adolescent self-efficacy and promote weight loss: methodology and design. BMC Public Health (2011) 1.10
Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial. Nutr J (2010) 1.09
Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney. Clin J Am Soc Nephrol (2012) 1.06
Regular exercise attenuates the metabolic drive to regain weight after long-term weight loss. Am J Physiol Regul Integr Comp Physiol (2009) 1.06
The impact of a managed care obesity intervention on clinical outcomes and costs: a prospective observational study. Obesity (Silver Spring) (2013) 1.06
Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis. Nutr J (2013) 1.06
Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc (2008) 1.06
Dietary approaches to the treatment of obesity. Psychiatr Clin North Am (2011) 1.04
Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial. Diabetes Care (2014) 1.03
Role of carbohydrate modification in weight management among obese children: a randomized clinical trial. J Pediatr (2012) 1.03
Trends and correlates in meat consumption patterns in the US adult population. Public Health Nutr (2010) 1.02
Weight loss and self-regulatory eating efficacy in older adults: the cooperative lifestyle intervention program. J Gerontol B Psychol Sci Soc Sci (2011) 1.00
Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr (2012) 1.00
Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res (2006) 1.00
Individual, facility, and program factors affecting retention in a national weight management program. BMC Public Health (2014) 0.98
A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program. Cardiovasc Diabetol (2009) 0.98
Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial. Am J Clin Nutr (2016) 0.98
Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol (2009) 0.96
Agricultural policies, food and public health. EMBO Rep (2010) 0.96
Obesity treatment: novel peripheral targets. Br J Clin Pharmacol (2009) 0.95
Effect of dietary adherence on the body weight plateau: a mathematical model incorporating intermittent compliance with energy intake prescription. Am J Clin Nutr (2014) 0.94
Macronutrient composition of the diet and prospective weight change in participants of the EPIC-PANACEA study. PLoS One (2013) 0.94
Nutrigenomics in cardiovascular medicine. Circ Cardiovasc Genet (2009) 0.93
Low or moderate dietary energy restriction for long-term weight loss: what works best? Obesity (Silver Spring) (2009) 0.93
Non alcoholic fatty liver disease: a clinical approach and review. Can J Gastroenterol (2006) 0.92
Vegetarian Diets and Weight Reduction: a Meta-Analysis of Randomized Controlled Trials. J Gen Intern Med (2016) 0.91
Considering patient diet preference to optimize weight loss: design considerations of a randomized trial investigating the impact of choice. Contemp Clin Trials (2013) 0.91
Dietary and physical activity adaptations to alternate day modified fasting: implications for optimal weight loss. Nutr J (2010) 0.91
Effectiveness of weight loss interventions--is there a difference between men and women: a systematic review. Obes Rev (2014) 0.91
Obesity and headache: Part II--potential mechanism and treatment considerations. Headache (2014) 0.90
Using personality as a predictor of diet induced weight loss and weight management. Int J Behav Nutr Phys Act (2011) 0.90
Update on obesity surgery. World J Gastroenterol (2006) 0.89
Protein intake during energy restriction: effects on body composition and markers of metabolic and cardiovascular health in postmenopausal women. J Am Coll Nutr (2007) 0.89
Dieting frequency in obese patients with binge eating disorder: behavioral and metabolic correlates. Obesity (Silver Spring) (2009) 0.89
Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health (2009) 0.88
A role for ΔFosB in calorie restriction-induced metabolic changes. Biol Psychiatry (2011) 0.88
Perilipin polymorphism interacts with dietary carbohydrates to modulate anthropometric traits in hispanics of Caribbean origin. J Nutr (2008) 0.88
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest (2009) 7.09
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA (2007) 6.95
Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA (2003) 6.17
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation (2006) 4.25
Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med (2002) 4.24
Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA (2002) 3.65
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med (2004) 3.49
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Parental perspectives on end-of-life care in the pediatric intensive care unit. Crit Care Med (2002) 2.81
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2010) 2.78
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol (2005) 2.61
Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med (2002) 2.59
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke (2006) 2.43
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem (2011) 2.33
Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke (2004) 2.22
Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation (2005) 2.21
Low-fat diets and weight change. JAMA (2006) 2.19
Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol (2002) 2.07
Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem (2004) 2.05
Emergency physicians' fear of malpractice in evaluating patients with possible acute cardiac ischemia. Ann Emerg Med (2005) 2.02
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2011) 2.01
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care (2011) 2.00
The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00
High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol (2004) 2.00
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis (2007) 1.93
Atypical presentations among Medicare beneficiaries with unstable angina pectoris. Am J Cardiol (2002) 1.92
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis (2004) 1.88
Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. J Lipid Res (2005) 1.83
Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol (2004) 1.80
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol (2004) 1.71
Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes (2009) 1.71
Volume-outcome relationship for coronary artery bypass grafting in an era of decreasing volume. Arch Surg (2008) 1.70
Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcomes (2013) 1.66
A percutaneous coronary intervention lab in every hospital? Circ Cardiovasc Qual Outcomes (2011) 1.63
Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. Am J Cardiol (2011) 1.60
Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score. Clin Infect Dis (2006) 1.54
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53
Metabolic and functional relevance of HDL subspecies. Curr Opin Lipidol (2011) 1.52
Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol (2002) 1.50
Use of the electrocardiograph-based thrombolytic predictive instrument to assist thrombolytic and reperfusion therapy for acute myocardial infarction. A multicenter, randomized, controlled, clinical effectiveness trial. Ann Intern Med (2002) 1.49
Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res (2006) 1.47
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion. Arterioscler Thromb Vasc Biol (2005) 1.43
Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clin Chem (2010) 1.43
Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke (2003) 1.36
Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease. Am J Cardiol (2008) 1.35
External validity of predictive models: a comparison of logistic regression, classification trees, and neural networks. J Clin Epidemiol (2003) 1.35
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care (2003) 1.35
Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the framingham study. J Clin Endocrinol Metab (2003) 1.35
Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients. Atherosclerosis (2005) 1.30
Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res (2009) 1.29
Improving the reliability of physician performance assessment: identifying the "physician effect" on quality and creating composite measures. Med Care (2009) 1.29
Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes (2010) 1.28
Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol (2005) 1.28
ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. J Lipid Res (2004) 1.28
Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther (2007) 1.28
Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr (2011) 1.26
Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr (2002) 1.26
Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. Arterioscler Thromb Vasc Biol (2003) 1.25
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins. Arterioscler Thromb Vasc Biol (2008) 1.25
Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol (2007) 1.25
Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2010) 1.24
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. J Lipid Res (2008) 1.21
Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res (2002) 1.19
Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. Am J Cardiol (2007) 1.17
Gender-specific association of a perilipin gene haplotype with obesity risk in a white population. Obes Res (2004) 1.17
Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Arch Neurol (2012) 1.17
Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res (2010) 1.16
Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults. J Nutr (2011) 1.15
Differences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal women. J Clin Endocrinol Metab (2005) 1.14
Random treatment assignment using mathematical equipoise for comparative effectiveness trials. Clin Transl Sci (2011) 1.14
Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol (2008) 1.14
Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J Lipid Res (2003) 1.13
High-density lipoprotein subpopulations in pathologic conditions. Am J Cardiol (2003) 1.13
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. Arterioscler Thromb Vasc Biol (2006) 1.13
Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism. J Lipid Res (2007) 1.10
Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J Nutr (2005) 1.10
Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am J Clin Nutr (2006) 1.09
Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels. Am J Cardiol (2007) 1.09
Obesity modulates the association among APOE genotype, insulin, and glucose in men. Obes Res (2003) 1.08
Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. Am J Med (2007) 1.08
Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab (2004) 1.07
Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am J Clin Nutr (2002) 1.06
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER. Atherosclerosis (2008) 1.06
Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2010) 1.05